IntelliCyt将产品销售扩展到中国的生命科学领域和药物研发市场 2013年6月5日，美国新墨西哥州Albuquerque市——IntelliCyte公司，一家为表型药物开发、抗体开发和体外毒性实验提供基于细胞和微珠的筛选解决方案的公司，宣布和上海典奥生物科技有限公司达成独家代理协议，由后者独家代理其产品在中国生命科学领域的推广和销售。典奥生物（Tekon）将在今天开始举办的SLAS亚洲会展上展示IntelliCyt的新产品iQue Screener。 IntelliCyt的CEO Terry Dunlay先生说：“典奥生物是一家领先的代理公司，在中国代理了世界范围的各种科学仪器，有超过25年的开拓生命科学仪器市场的经验。”“我们满怀激动地将我们的基于细胞和微珠的筛选解决方案推广到中国，我们的合作伙伴将有强大的潜能将我们的仪器介绍给药学、生物技术和生命科学领域的新客户，以保证我们的产品线的持续增长。” “我们一直在寻找中国生命科学市场对基于细胞和微珠的筛选的灵活性的需求。”典奥生物的CEO David Hadfield先生如是说：“IntelliCyt的平台能对主要的免疫系统细胞和其他溶液中的细胞进行快速经济的筛选并评估化合物对细胞的影响，这是满足中国市场需求的关键。” 关于典奥生物（Tekon Biotech） 典奥生物成立于1988年，为中国生命科学市场销售和提供广泛的产品和技术。典奥的客户包括所有主要的药物开发公司、生物技术公司和中国前50名的大学和研究所。典奥生物的总部在上海，并在香港和台北设有分公司。典奥生物以能提供最好的服务和技术支持为骄傲。更多信息，请访问：www.tekontech.com 关于IntelliCyt公司 IntelliCyt公司为表型药物开发、抗体开发和体外毒性实验提供创新的、高通量、高内涵的基于细胞和微珠的筛选解决方案。IntelliCyt的专利的技术、仪器、试剂和软件产品满足药物研发领域、生物技术和生命科学领域对增加生产效率的普遍的需求，并为这种需求提供整体的解决方案。更多信息，请访问：www.intellicyt.com 联系方式 IntelliCyt Corporation 中国（大陆、香港、澳门、台湾）总代理 上海典奥生物科技有限公司 上海市浦东大道1139弄惠扬大厦6号楼2101室，上海，200135，中国 电话：（+86-21）5860.5185 传真：（+86-21）5197.3282 Email：sales@tekon.net 网址：www.tekontech.com IntelliCyt and Tekon Biotech Announce China Distribution Agreement ]IntelliCyt Expands Product Sales to Life Science and Pharmaceutical Markets in China Albuquerque, NM, June 5, 2013 — IntelliCyt Corporation, a provider of cell and bead-based screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced an exclusive agreement with Tekon Biotech to distribute their products in the Chinese life science arena. Tekon will feature IntelliCyt’s new iQue™ Screener at the SLAS China conference, starting today in Shanghai. “Tekon is a leading distributor of world-class scientific products in China with over 25 years of experience in the life science systems and tools market”, commented Terry Dunlay, CEO at IntelliCyt. “We are excited about expanding our cell and bead-based screening solutions business into China, and the powerful potential this partnership has to reach new pharma, biotech, and life science customers for continued growth of our product line.” “We are seeing increased need for both cell and bead-based screening flexibility in the Chinese life science market”, said David Hadfield, CEO of Tekon Biotech. “The capability of IntelliCyt platforms to screen large libraries and evaluate compound effects on primary immune system cells and other cells in solution rapidly and in a cost efficient manner is key to addressing this need.” About Tekon Biotech Tekon Biotech, founded in 1988, sells and supports a broad range of technologies to the China life sciences market. Tekon’s customers include all the major pharmaceutical and biotech companies plus the top 50 universities. Tekon is headquartered in Shanghai with offices in Hong Kong and Taipei. Tekon Biotech takes pride in providing the best service and technical support. For more information, visit www.tekontech.com. About IntelliCyt Corporation Contacts: IntelliCyt Corporation 中国（大陆、香港、澳门、台湾）总代理 上海典奥生物科技有限公司 上海市浦东大道1139弄惠扬大厦6号楼2101室，上海，200135，中国 电话：（+86-21）5860.5185 传真：（+86-21）5197.3282 Email：sales@tekon.net 网址：www.tekontech.com
Michael Sjaastad, Director of Business Development
505-345-9075
MSjaastad@intellicyt.com
IntelliCyt Corporation develops innovative, high-throughput, high-content cell and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery and in vitro toxicity testing. IntelliCyt’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology, and life science research. For more information, please visit www.intellicyt.com.
Michael Sjaastad, Director of Business Development
505-345-9075
MSjaastad@intellicyt.com
上海典奥生物科技有限公司商家主页
地址：上海浦东新区东靖路1831号3楼301室
联系人：刘映薇
电话：021-58605185-822
传真：021-58901159
Email：marketing@tekon.com.cn
本文链接： http://discovery.immuno-online.com/view-1370726490.html
